CEO, Partner. Bachelor of Economics, Victoria University, Canada. Master of Financial Management, The Chinese University of Hong Kong. FMBA, Tsinghua University. Cheung Kong Graduate School of Business. Mr Wang founded Zhengfutong (Beijing) Investment Co., Ltd. and CQY Capital.

President, Partner. Bachelor of Statistics with First Honor, University College London. Mr Ni worked for China Renaissance as the senior analyst of domestic capital markets department, participated in and completed several private equity projects in Internet industry.

Partner. Georgia Institute of Technology. Cheung Kong Graduate School of Business Mr. Zhu was the general manager of Suzhou L.J.T Intelligent and Technology Co., LTD. Mr. Zhu is the director of Gold Mantis, VP of Suzhou Gold Mantis Construction Decoration Co., LTD, the director of Gold Mantis Landscape, the director of Gold Mantis Assert Management LTD., the director of SINGAPORE GOLD MANTIS PTE. LTD. Mr. Zhu owns rich experience in real estate, architecture and manufacturing industry.

Partner. Master of business, University of Birmingham and University of Kent,. Cheung Kong Graduate School of Business. Mr. Wu was the director of Guangdong Biolight Meditech Co.,Ltd. Mr. Wu is the chairman of the Board of Cloudoc, vice chairman of the board of Jiangsu Yuyue medical equipment & supply Co., Ltd. and director of Flowers King Ecological Engineering CO.,LTD. Mr. Wu focuses on healthcare industry, he has succeeded in investing on several domestic and foreign companies in healthcare industry.

Partner. Bachelor degree. Cheung Kong Graduate School of Business. Mr. Han is the chairman of Five Bulls Fund and vice chairman of the Board of Hywing Group. Mr. Han focuses on finance industry in China for years. He had completed investments and M&A for several public companies and large real estate and lead several private equity funds, The management scale of Five Bulls Fund is more than 30 billion RMB.

Senior assistant of Price Waterhouse Cooper, and take charge of M&A, listed company, IPO audit, and due diligence.

Focus on private equity and corporate law. Graduated from Temple University, as part of a joint program with Tsinghua with a concentration on American and international law. Master of Laws degree, a Bachelor of Laws, and a Bachelor of Arts. Interned at AnJie Law Firm in Beijing and Blank Rome LLP In Philadelphia.

Hold a master's degree in Chemistry from the University of St. Andrews in the United Kingdom. Research interests include transaminase inhibitors in the RMA of tuberculosis virus. PhD studied in the School of Pharmacy, Shanghai Jiaotong University. During this period, she was mainly focused in the research of asymmetric chiral hydrogenation reactions, and engaged in the industrialization of artemisinin.

Founding Partner of CDH. Board Chairman of multiple listed companies. “Top 30 Most Influential Investors in China” for many years. Leading Investor of multiple large IPOs in A/H Share and US stock market. Acquired Sirtex for 10 billion RMB with Grand Pharmaceutical.

Chairman and CEO of Yuwell Medical, Chairman of Wandong Medical. Participated in multiple health care investments including Biolight Meditech, Kangli etc.